SCHEMBL23355436

SCHEMBL23355436

COC(=O)c1ccc2c(-c3c(F)cccc3F)c(C)nn2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ OPRM1 P35372 1/20 0.38
▸ MAPK14 Q16539 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ F2RL3 Q96RI0 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23355447 0.92 MAPK14 (0.43) JAK1TYK2KMT2AALDH1A1OPRM1
SCHEMBL30933433 0.92 MAPK14 (0.43) JAK1TYK2KMT2AALDH1A1OPRM1
SCHEMBL29273408 0.86 TTR (0.45) KMT2AALDH1A1MAPK14NPC1MAPT
SCHEMBL29273416 0.78 RORC (0.41) CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL23355474 0.76 TDP1 (0.42) KMT2AALDH1A1OPRM1MAPK14KDM4E
SCHEMBL23355443 0.73 KMT2A (0.38) KMT2AALDH1A1KDM4ENPC1MAPT
SCHEMBL23355462 0.72 KDM4E (0.45) KMT2AALDH1A1KDM4ENPC1HTT
SCHEMBL23355480 0.71 KMT2A (0.37) KMT2AALDH1A1KDM4ENPC1MAPT
SCHEMBL24251609 0.71 KMT2A (0.37) KMT2AALDH1A1KDM4ENPC1MAPT
SCHEMBL23355473 0.71 KMT2A (0.36) KMT2AALDH1A1KDM4ENPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243197-A1 Anthelmintic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2025-07-31 — — US disclosed
US-12269822-B2 Anthelminthic heterocyclic compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2025-04-08 — — US disclosed
CN-112996788-B Anthelmintic heterocyclic compounds 勃林格殷格翰动物保健美国公司 2024-07-16 — — CN disclosed
US-20220048903-A1 Anthelminthic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2022-02-17 — — US disclosed
US-20220048903-A1 Anthelminthic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2022-02-17 — — US disclosed
CN-112996788-A Anthelmintic heterocyclic compounds 勃林格殷格翰动物保健美国公司 2021-06-18 — — CN disclosed
EP-3820870-A1 ANTHELMINTHIC HETEROCYCLIC COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2021-05-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048903-A1 Anthelminthic Heterocyclic Compounds SDHA, PAH, PIGS JAK1 3245/4885TYK2 4263/4885KMT2A 1440/4885
US-12269822-B2 Anthelminthic heterocyclic compounds SDHA, PAH, PIGS JAK1 3245/4885TYK2 4263/4885KMT2A 1440/4885
US-20250243197-A1 Anthelmintic Heterocyclic Compounds PAH, PIGS, SDHA JAK1 3386/4885TYK2 4323/4885KMT2A 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback